At3g28610 Antibody

Shipped with Ice Packs
In Stock

Description

Basic Characterization of At3g28610 Antibody

Target Protein: At3g28610 (UniProt ID: Q9LJJ5)
Host Species: Immunoglobulin derived from mammalian systems (exact host unspecified)
Application: Primarily used for immunodetection in plant biology research (e.g., Western blot, ELISA, immunohistochemistry) .

Biological Context of At3g28610

  • Gene Function: At3g28610 is annotated as a putative protein-coding gene in Arabidopsis, though its specific biological role remains uncharacterized in peer-reviewed literature.

  • Protein Features:

    • Molecular weight: Unreported (requires experimental verification)

    • Subcellular localization: Unknown

    • Post-translational modifications: No data available

Potential Uses

  • Comparative Studies: Could aid in evolutionary analyses of conserved plant proteins .

  • Developmental Biology: May help map expression patterns during Arabidopsis growth stages.

Current Limitations

  • No published studies using this antibody were identified in academic databases (PubMed, Frontiers, etc.).

  • Commercial documentation lacks validation data (e.g., Western blot images, specificity tests) .

Technical Considerations

  • Cross-Reactivity Risk: Antibodies targeting plant proteins often exhibit off-target binding due to conserved domains across plant species. Independent validation is critical .

  • Storage: Likely requires aliquoting at -20°C to preserve activity (standard for IgG antibodies) .

Future Research Directions

  1. Functional Studies: CRISPR/Cas9 knockout lines paired with this antibody could clarify At3g28610’s role.

  2. Structural Biology: Cryo-EM or X-ray crystallography might reveal interactions with other plant proteins .

  3. Agricultural Relevance: If linked to stress response pathways, could inform crop engineering .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At3g28610 antibody; MZN14.7AAA-ATPase At3g28610 antibody; EC 3.6.1.3 antibody
Target Names
At3g28610
Uniprot No.

Q&A

What is the At3g28610 protein and why are antibodies against it important in research?

At3g28610 refers to a specific locus in the Arabidopsis thaliana genome that encodes a protein involved in cellular signaling pathways. Antibodies targeting this protein are valuable research tools for studying its expression, localization, and function in plant stress responses and development. These antibodies enable detection of protein expression patterns across different tissues, developmental stages, and stress conditions through various immunological techniques. The functional analysis of At3g28610 contributes to our understanding of plant signaling networks, particularly those involving MAP kinase cascades similar to mammalian systems like ASK1/MAP3K5 . Appropriate antibody selection is critical for obtaining reliable experimental results when investigating this signaling protein's role in plant biology.

What detection methods work best with At3g28610 antibodies?

At3g28610 antibodies can be successfully employed across multiple detection platforms, though optimization for each method is essential. Based on approaches used with similar antibodies, the following techniques have proven effective:

Detection MethodTypical DilutionSample PreparationAdvantages
Western Blotting1:500-1:2000Denaturing conditions with reducing agentsMolecular weight confirmation, semi-quantitative analysis
Immunofluorescence1:100-1:500Paraformaldehyde fixation, permeabilizationSubcellular localization, tissue distribution
Immunohistochemistry (IHC-P)1:50-1:200Paraffin-embedded sectionsTissue-specific expression patterns
ELISA1:1000-1:5000Protein extraction in non-denaturing buffersQuantitative analysis
Immunoprecipitation1:50-1:100Mild lysis conditionsProtein-protein interaction studies

The choice of detection method should align with research objectives, with Western blotting and immunofluorescence providing complementary data on protein expression and localization. Each technique requires specific optimization for signal-to-noise ratio and specificity validation .

How should I validate the specificity of At3g28610 antibodies?

  • Genetic controls: Compare antibody reactivity in wild-type versus knockout/knockdown lines lacking At3g28610 expression

  • Recombinant protein controls: Test antibody against purified At3g28610 protein

  • Peptide competition assays: Pre-incubate antibody with the immunizing peptide to demonstrate signal reduction

  • Cross-reactivity assessment: Test against related proteins, particularly other MAP kinase cascade components

  • Multiple antibody comparison: Use antibodies targeting different epitopes of At3g28610

The absence of signal in knockout lines coupled with specific single-band detection at the expected molecular weight in Western blots provides strong evidence for antibody specificity. Additionally, immunoprecipitation followed by mass spectrometry can confirm the identity of the captured protein .

How can At3g28610 antibodies be used to study protein-protein interactions in signaling cascades?

At3g28610 antibodies can provide valuable insights into protein-protein interactions within plant signaling networks using several advanced approaches:

  • Co-immunoprecipitation (Co-IP): Using At3g28610 antibodies to pull down the protein complex from plant extracts, followed by mass spectrometry to identify interacting partners. This approach has revealed novel interactions in similar MAP kinase pathways.

  • Proximity ligation assay (PLA): Combining At3g28610 antibodies with antibodies against suspected interaction partners to visualize protein proximity within cells.

  • Immunoprecipitation coupled with biophysical modeling: Similar to approaches used for other signaling proteins, computational models can predict how antibody binding affects protein interactions under different conditions .

The statistical-physics-based model described in the literature for antibody-protein interactions can be adapted to study how At3g28610 interacts with downstream effectors in response to environmental stressors. This model would incorporate binding affinities, binding site locations, and concentration dependencies to predict interaction dynamics .

For quantitative assessment of interactions, researchers should consider the competitive binding principles that may affect antibody accessibility when At3g28610 is engaged in protein complexes. These methodological considerations are essential for accurate interpretation of interaction data.

What experimental design considerations are important when using At3g28610 antibodies for stress response studies?

When investigating At3g28610's role in stress responses, experimental design must account for:

  • Temporal dynamics: Sample collection at multiple time points (e.g., 0, 15, 30, 60, 120 minutes post-stress) to capture rapid signaling events

  • Stress specificity: Comparison across multiple stressors (oxidative, salt, drought, pathogen) to determine pathway specificity

  • Tissue specificity: Sampling from different plant tissues to assess differential responses

  • Antibody combinations: Using phospho-specific antibodies alongside total At3g28610 antibodies to monitor activation state

  • Genetic backgrounds: Including relevant mutants in upstream/downstream pathway components

A typical experimental framework would include:

Experimental GroupStress TreatmentTime Points (min)Tissues SampledControls
Wild-typeH₂O₂ (5mM)0, 15, 30, 60, 120Leaves, rootsUntreated
Wild-typeNaCl (150mM)0, 15, 30, 60, 120Leaves, rootsUntreated
Pathway mutantH₂O₂ (5mM)0, 15, 30, 60, 120Leaves, rootsUntreated
At3g28610 knockoutAll treatmentsAll time pointsAll tissuesUntreated

This design enables assessment of At3g28610 protein levels, post-translational modifications, and subcellular relocalization in response to stress stimuli. The inclusion of genetic controls helps establish pathway specificity and position At3g28610 within the signaling cascade .

How can I develop quantitative assays for At3g28610 protein levels using antibodies?

Developing robust quantitative assays for At3g28610 requires careful consideration of antibody characteristics and assay design:

  • ELISA development:

    • Coat plates with capture antibody recognizing one epitope

    • Use detection antibody recognizing a different epitope

    • Develop standard curves using recombinant At3g28610 protein

    • Validate dynamic range and sensitivity

  • Quantitative Western blotting:

    • Include internal loading controls (housekeeping proteins)

    • Prepare standard curves with recombinant protein

    • Use fluorescent secondary antibodies for better linearity

    • Apply digital image analysis for band quantification

  • Microflow LC-MS/MS approach:

    • Immunoprecipitate At3g28610 using validated antibodies

    • Process samples for LC-MS/MS analysis

    • Quantify using methods similar to those applied for therapeutic antibodies

For optimal quantification, researchers should establish a linear dynamic range for their assay. Based on similar approaches with other antibodies, a 3-order magnitude dynamic range (0.1-100 ng) can be achieved with proper optimization . This allows for sensitive detection of both basal expression and induced levels following stress treatments.

What are the most common causes of non-specific binding with At3g28610 antibodies and how can they be addressed?

Non-specific binding is a frequent challenge with plant protein antibodies due to cross-reactivity with related proteins or matrix components. Common causes and solutions include:

IssuePossible CausesSolution Strategies
Multiple bands in Western blotCross-reactivity with related proteins; Protein degradationIncrease antibody dilution; Add protease inhibitors; Use knockout controls; Perform peptide competition
High background in immunofluorescenceInsufficient blocking; Secondary antibody cross-reactivityExtend blocking time; Use alternative blocking agents (BSA, normal serum); Include detergents in wash buffers
False positives in immunoprecipitationNon-specific binding to beads; Protein-protein interactionsUse pre-clearing step; Increase salt concentration in wash buffers; Include knockout controls
Inconsistent results between techniquesEpitope accessibility varies between methodsUse antibodies targeting different epitopes; Modify fixation/extraction protocols

When troubleshooting, a systematic approach is essential. Start by validating the antibody using known positive and negative controls. For plant proteins like At3g28610, include tissue-specific controls and consider potential interference from abundant plant compounds like polyphenols and polysaccharides that can affect antibody binding .

How can I optimize fixation and extraction protocols for At3g28610 detection in different plant tissues?

Optimization of fixation and extraction protocols is critical for successful At3g28610 detection across different plant tissues:

  • Protein extraction optimization:

    • For Western blotting: Compare different extraction buffers (RIPA, Tris-based, phosphate-based) with varying detergent concentrations

    • For membrane-associated proteins: Include appropriate detergents (NP-40, Triton X-100)

    • For nuclear proteins: Use specific nuclear extraction protocols with sonication

    • Always include protease/phosphatase inhibitors to prevent degradation and modification loss

  • Tissue fixation for microscopy:

    • Test multiple fixatives: 4% paraformaldehyde, glutaraldehyde, or combinatorial approaches

    • Optimize fixation time: Too short leads to inadequate preservation; too long can mask epitopes

    • Consider alternative antigen retrieval methods for paraffin-embedded sections

    • For challenging tissues, evaluate cryofixation methods

A methodical optimization approach would include testing a matrix of conditions:

Extraction ParameterTest RangeEvaluation Method
Buffer pH6.8, 7.4, 8.0Western blot band intensity
Salt concentration100mM, 150mM, 300mMProtein yield and specific signal
Detergent typeNP-40, Triton X-100, CHAPSMembrane protein extraction efficiency
Fixation time10min, 30min, 60minSignal-to-noise in immunofluorescence

Document all optimization steps systematically, as the optimal conditions may vary between developmental stages and stress treatments .

What approaches can resolve contradictory results between different detection methods using At3g28610 antibodies?

When facing contradictory results between different detection methods, consider these systematic resolution approaches:

  • Epitope accessibility assessment:

    • Different methods expose different protein conformations

    • Use antibodies targeting different epitopes

    • Consider native versus denatured conditions

  • Methodological validation:

    • Confirm specificity in each method using genetic controls

    • Verify protein identity by mass spectrometry following immunoprecipitation

    • Use complementary approaches (e.g., fluorescent protein tagging) to confirm localization

  • Data integration framework:

    • Develop a comprehensive model incorporating all data points

    • Assign confidence levels to different methodologies

    • Identify conditions under which contradictions occur

  • Statistical analysis:

    • Apply appropriate statistical tests to determine significance of differences

    • Consider biophysical modeling to explain binding differences under various conditions

When interpreting contradictory results, it's important to recognize that different methods reveal different aspects of protein biology. For example, cross-linking during fixation may alter epitope accessibility in immunofluorescence but not affect Western blotting results. Document all experimental conditions meticulously to identify potential variables causing discrepancies .

How can computational modeling enhance the interpretation of At3g28610 antibody binding data?

Computational modeling offers powerful approaches for understanding complex antibody-antigen interactions for proteins like At3g28610:

  • Statistical-physics-based modeling:

    • Incorporates binding site locations, affinities, and concentration dependencies

    • Predicts competitive binding in complex samples

    • Simulates how binding is affected by experimental conditions

  • Epitope mapping and accessibility prediction:

    • Combines structural bioinformatics with experimental data

    • Predicts epitope exposure under different conditions

    • Informs antibody selection for specific applications

  • Quantitative binding models:

    • Analyzes kinetic parameters (kon, koff, KD)

    • Incorporates concentration effects on binding

    • Predicts detection limits and optimal concentrations

Implementing these approaches requires:

  • Experimentally determined binding parameters

  • Structural information (if available) or predicted models

  • Statistical validation against experimental controls

These computational tools can help resolve apparent contradictions in experimental data by providing a theoretical framework for understanding how factors like protein conformation, binding competition, and experimental conditions affect antibody interactions .

What are the best practices for multiplexing At3g28610 antibodies with other antibodies for pathway analysis?

Multiplexing antibodies enables comprehensive pathway analysis but requires careful experimental design:

  • Antibody compatibility assessment:

    • Select antibodies raised in different host species

    • Verify lack of cross-reactivity between secondary antibodies

    • Test for epitope interference when targeting interacting proteins

  • Multiplexed Western blotting strategies:

    • Sequential probing with stripping between antibodies

    • Simultaneous detection using spectrally distinct fluorescent secondaries

    • Size-based separation for proteins with different molecular weights

  • Multiplexed immunofluorescence:

    • Use primary antibodies from different species

    • Employ spectrally distinct fluorophores with minimal overlap

    • Include appropriate controls for bleed-through and cross-reactivity

  • Quantitative considerations:

    • Validate dynamic range for each antibody individually

    • Assess potential signal interference in multiplexed setting

    • Include single-stained controls alongside multiplexed samples

For studying At3g28610 in signaling cascades, combining antibodies against upstream activators, At3g28610 itself, and downstream targets provides comprehensive pathway insights. This approach is particularly valuable for capturing the temporal dynamics of stress responses in plant systems .

What emerging technologies will enhance At3g28610 antibody research in the coming years?

Several cutting-edge technologies are poised to transform antibody-based research for proteins like At3g28610:

  • Nanobody and single-domain antibody approaches:

    • Smaller size enables better tissue penetration

    • Higher stability under varying conditions

    • Potential for detecting previously inaccessible epitopes

    • Improved specificity for closely related protein family members

  • Mass spectrometry-based validation and quantification:

    • Integration of antibody-based enrichment with MS detection

    • Absolute quantification of protein levels

    • Comprehensive post-translational modification mapping

    • Enhanced specificity through peptide-level identification

  • Spatial biology techniques:

    • Highly multiplexed imaging using antibody cycling or spectral unmixing

    • Single-cell resolution of protein expression and modification

    • 3D reconstruction of protein localization within tissues

    • Correlation of protein patterns with transcriptomic data

  • Computational antibody development:

    • In silico prediction of optimal epitopes for At3g28610

    • Structure-based antibody engineering for improved specificity

    • Machine learning approaches to predict cross-reactivity

    • Models to optimize antibody panels for pathway analysis

These emerging approaches will enable more comprehensive characterization of At3g28610's role in plant biology, with higher specificity, sensitivity, and content-rich data that integrates multiple aspects of protein function .

What are the key considerations for publishing research using At3g28610 antibodies?

When publishing research utilizing At3g28610 antibodies, researchers should address several critical aspects to ensure reproducibility and reliability:

  • Comprehensive antibody validation:

    • Document specificity testing (e.g., knockout controls, peptide competition)

    • Report lot numbers and sources

    • Include validation data in supplementary materials

    • Describe all optimization procedures

  • Detailed methodological reporting:

    • Provide complete protocols with antibody dilutions, incubation times, and buffer compositions

    • Specify imaging parameters for microscopy or detection settings for Western blotting

    • Include all positive and negative controls

    • Report replicate numbers and statistical analyses

  • Data interpretation transparency:

    • Acknowledge limitations of antibody-based approaches

    • Address potential alternative interpretations

    • Correlate antibody-based findings with orthogonal methods

    • Discuss implications within the broader context of plant biology

These considerations align with emerging standards for antibody-based research publications and will facilitate reproducibility across different research groups investigating plant signaling mechanisms .

How can At3g28610 antibody research contribute to broader understanding of plant stress response mechanisms?

Research utilizing At3g28610 antibodies can advance our understanding of plant stress responses through:

  • Pathway integration:

    • Mapping At3g28610's position within signaling networks

    • Identifying novel interaction partners through co-immunoprecipitation

    • Determining tissue-specific activation patterns

    • Correlating protein modifications with specific stressors

  • Temporal dynamics:

    • Characterizing rapid signaling events following stress perception

    • Monitoring protein degradation and turnover

    • Tracking subcellular relocalization in response to stimuli

    • Correlating protein-level changes with transcriptional responses

  • Comparative biology:

    • Investigating conservation of signaling mechanisms across plant species

    • Relating plant MAP kinase cascades to mammalian systems like ASK1

    • Identifying unique features of plant-specific responses

    • Connecting molecular mechanisms to physiological adaptations

These approaches contribute to fundamental knowledge of plant biology while potentially informing agricultural applications for improving crop stress resilience through the detailed understanding of molecular signaling networks .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.